<DOC>
	<DOC>NCT01006005</DOC>
	<brief_summary>The study is recruiting 50 patients initiating or switching to Atripla and comparing them to 250 individuals previously followed in a prospective study of HIV+ low income individuals recruited from homeless shelters, single room occupancy hotels and free meal food lines as part of the UCSF Reach Study. Adherence will be measured through monthly unannounced pill counts and electronic medication monitors.</brief_summary>
	<brief_title>Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<criteria>18+ years old; HIV+; Initiating Atripla within 6months of recruitment; Lives in the Tenderloin, South of Market, or Mission District San Francisco; Capable of providing informed consent; and Willing to complete all study procedures. Intoxication, cognitive dysfunction or psychosis will preclude potential subjects from informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>Treatment experienced</keyword>
</DOC>